GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $83.77 $93.35 Thursday, 18th Apr 2024 BMRN stock ended at $90.07. This is 0.442% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 1.59% from a day low at $89.78 to a day high of $91.20.
90 days $83.44 $94.51
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2020-08-13 $118.61 $118.61 $115.78 $116.87 1 123 316
2020-08-12 $117.00 $118.98 $117.00 $118.02 1 006 858
2020-08-11 $117.71 $118.82 $116.40 $116.83 980 204
2020-08-10 $118.35 $118.66 $116.06 $118.25 785 280
2020-08-07 $119.84 $120.75 $117.81 $118.67 734 633
2020-08-06 $119.60 $120.66 $118.36 $119.65 642 581
2020-08-05 $119.99 $124.52 $118.77 $119.83 1 373 350
2020-08-04 $122.69 $122.69 $118.15 $119.83 1 128 384
2020-08-03 $120.35 $122.47 $118.78 $122.04 1 072 655
2020-07-31 $121.81 $121.93 $117.72 $119.81 954 864
2020-07-30 $119.21 $123.19 $118.20 $121.72 815 786
2020-07-29 $123.67 $123.67 $120.19 $120.53 1 025 776
2020-07-28 $124.46 $124.46 $121.80 $122.83 885 436
2020-07-27 $124.08 $124.90 $122.63 $124.00 948 809
2020-07-24 $123.41 $124.99 $121.63 $122.95 1 178 233
2020-07-23 $127.99 $129.18 $124.33 $124.49 966 656
2020-07-22 $129.06 $130.16 $126.44 $127.58 1 038 100
2020-07-21 $130.97 $131.94 $129.03 $129.89 761 600
2020-07-20 $128.89 $131.72 $128.26 $131.03 1 113 200
2020-07-17 $128.54 $129.34 $126.81 $128.21 932 600
2020-07-16 $126.74 $128.63 $124.47 $127.78 1 067 800
2020-07-15 $126.21 $127.36 $124.68 $126.74 936 000
2020-07-14 $123.20 $126.87 $119.51 $126.43 1 365 100
2020-07-13 $126.65 $130.04 $123.82 $124.40 1 713 000
2020-07-10 $126.61 $127.40 $124.99 $126.06 801 800
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT